Arexvy Kit
Product Images NDC 58160-882
Product Visual Gallery
This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Arexvy (NDC 58160-882). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Glaxosmithkline Biologicals Sa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Arexvy Spl Graphic 02)
Figure 3 (Arexvy Spl Graphic 03)
Figure 4 (Arexvy Spl Graphic 04)
Figure 1 (Arexvy Spl Graphic 05)
Figure 2 (Arexvy Spl Graphic 06)
Figure 3 (Arexvy Spl Graphic 07)
Figure 4 (Arexvy Spl Graphic 08)
Arexvy 10 Dose Carton (Arexvy Spl Graphic 09)
Arexvy Antigen Vial Label (Arexvy Spl Graphic 10)
Arexvy Adjuvant Vial Label (Arexvy Spl Graphic 11)
Arexvy 1 Dose Carton (Arexvy Spl Graphic 12)
Arexvy Antigen Vial Label (Arexvy Spl Graphic 13)
Arexvy Adjuvant Syringe Label (Arexvy Spl Graphic 14)
Arexvy 10 Dose Carton (Arexvy Spl Graphic 15)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.